These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17086519)

  • 21. [Outcome of transcatheter closure of perimembranous ventricular septal defect with modified double-disk occluder device].
    Liu J; You XH; Zhao XX; Hu JQ; Cao J; Xu RL; Wu H; Chen SP; Zhang JL; Zheng X; Qin YW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Apr; 38(4):321-5. PubMed ID: 20654076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Percutaneous closure of ventricular septal defect by Amplatzer occluder. Immediate and mid-term follow up results].
    Zabal C; García Montes JA; Calderón Colmenero J; Patiño Bahena E; Buendía Hernández A; Attie F
    Arch Cardiol Mex; 2005; 75(3):327-34. PubMed ID: 16294823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Closure of perimembranous ventricular septal defect using transcatheter technique versus surgical repair.
    Pawelec-Wojtalik M; Wojtalik M; Mrówczyński W; Surmacz R
    Kardiol Pol; 2005 Dec; 63(6):595-602; discussion 603-4. PubMed ID: 16380857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcatheter closure of congenital ventricular septal defects in adult: mid-term results and complications.
    Chessa M; Butera G; Negura D; Bussadori C; Giamberti A; Fesslova V; Carminati M
    Int J Cardiol; 2009 Mar; 133(1):70-3. PubMed ID: 18234370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects.
    Butera G; Carminati M; Chessa M; Delogu A; Drago M; Piazza L; Giamberti A; Frigiola A
    Am Heart J; 2004 Sep; 148(3):507-10. PubMed ID: 15389240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Device closure of large atrial septal defects requiring devices > or =20 mm in small children weighing <20 kg.
    Dalvi B; Pinto R; Gupta A
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):679-86. PubMed ID: 18360866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II].
    Zhao PJ; Yu ZQ; Gao W; Li F; Fu LJ; Liu TL; Li Y; Zhang YQ; Huang MR; Guo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Oct; 40(10):817-20. PubMed ID: 23302666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder.
    Qin Y; Chen J; Zhao X; Liao D; Mu R; Wang S; Wu H; Guo H
    Am J Cardiol; 2008 Jun; 101(12):1781-6. PubMed ID: 18549859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Outcome of interventional therapy of perimembranous ventricular septal defects].
    Hu HB; Jiang SL; Xu ZY; Huang LJ; Zhao SH; Zheng H; Ling J; Zhang GJ; Wang H; Wang Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jul; 37(7):618-21. PubMed ID: 19961733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter closure of perimembranous ventricular septal defect using Amplatzer ductal occluder.
    Lee SM; Song JY; Choi JY; Lee SY; Paik JS; Chang SI; Shim WS; Kim SH
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1141-6. PubMed ID: 23554093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A monocenter experience of ventricular septal defects treated by catherization].
    Paoli F; Dragulescu A; Amedro P; Ovaert C; Mas B; Ghez O; Metras D; Kreitmann B; Fraisse A
    Arch Mal Coeur Vaiss; 2007 May; 100(5):380-5. PubMed ID: 17646761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
    Ewert P; Söderberg B; Dähnert I; Hess O; Schuler G; Bussmann C; Bernhard J; Sick P
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):398-402. PubMed ID: 18288739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry.
    Holzer R; de Giovanni J; Walsh KP; Tometzki A; Goh T; Hakim F; Zabal C; de Lezo JS; Cao QL; Hijazi ZM
    Catheter Cardiovasc Interv; 2006 Oct; 68(4):620-8. PubMed ID: 16969878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter closure of high-risk muscular ventricular septal defects with the CardioSEAL occluder: initial report from the CardioSEAL VSD registry.
    Lim DS; Forbes TJ; Rothman A; Lock JE; Landzberg MJ
    Catheter Cardiovasc Interv; 2007 Nov; 70(5):740-4. PubMed ID: 17621665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First experience with the BioSTAR-device for various applications in pediatric patients with congenital heart disease.
    Hoehn R; Hesse C; Ince H; Peuster M
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):72-7. PubMed ID: 19787660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis and follow-up study on 8 children with combined congenital heart disease treated with simultaneous trans-catheter therapy].
    Cheng SQ; Liu JP; Sun X; Li J; Zhang J; Liu LW; Deng YL; Niu YC
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):599-602. PubMed ID: 18947479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of results and complications of surgical and Amplatzer device closure of perimembranous ventricular septal defects.
    Xunmin C; Shisen J; Jianbin G; Haidong W; Lijun W
    Int J Cardiol; 2007 Aug; 120(1):28-31. PubMed ID: 17084470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder in adult patients: our first clinical experiences].
    Kaya MG; Ozdoğru I; Baykan A; Doğan A; Inanç T; Doğdu O; Uzüm K; Narin N; Topsakal R; Ergin A; Oğuzhan A; Eryol NK
    Turk Kardiyol Dern Ars; 2008 Jul; 36(5):287-93. PubMed ID: 18984979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk factors for early arrhythmias post transcatheter closure of perimembranous ventricular septal defects].
    Zhu XY; Liu YH; Hou CJ; Han XM; Sheng XT; Zhang DZ; Cui CS; Wang QG; Deng DA; Zhang YW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):633-6. PubMed ID: 17961429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant aortic regurgitation associated with transcatheter closure of perimembranous ventricular septal defects with a deficient aortic rim.
    Kenny D; Tometzki A; Martin R
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):445-9. PubMed ID: 17721940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.